Conceptus
Medical Equipment Manufacturing • 
United States • 51-100 Employees
Company overview
| Headquarters | United States |
| Phone number | +18888422937 |
| Websites | |
| NAICS | 3391 |
| SIC | 283 |
| Founded | 1992 |
| Employees | 51-100 |
| Socials |
Key Contact at Conceptus
Louis Villalba
European Vice President
Conceptus Email Formats
Conceptus uses 5 email formats. The most common is {first name}.{last name}@company.com (e.g., john.doe@company.com), used 48.2% of the time.
| Format | Example | Percentage |
|---|---|---|
{first name}.{last name}@company.com | john.doe@company.com | 48.2% |
{first name initial}{last name}@company.com | {first name initial}doe@company.com | 24.1% |
{first name}@company.com | john@company.com | 12.4% |
{last name}.{first name}@company.com | doe.john@company.com | 8.9% |
{first name}{last name}@company.com | johndoe@company.com | 6.4% |
About Conceptus
Conceptus, Inc. is a leader in the design, development, and marketing of innovative solutions in women's healthcare. The Company manufactures and markets the Essure procedure, which was FDA approved in 2002 and is the first permanent birth control method that can be performed in the comfort of a physician's office in less than 10 minutes (average hysteroscopic time) without hormones, cutting, burning or the risks associated with general anesthesia or tubal ligation. Soft, flexible inserts are placed in a woman's fallopian tubes through the cervix without incisions. Over the next three months, the body forms a natural barrier around the micro-inserts to prevent sperm from reaching the egg. The Essure procedure is 99.95% effective based on one year of follow up with zero pregnancies reported in clinical trials, making it the most effective form of permanent birth control on the market. The procedure is covered by most insurance plans, and when it is performed in a doctor's office the cost to the patient may be as low as a simple co-pay. Three months after the Essure procedure, a doctor is able to perform an Essure Confirmation Test to confirm that the inserts are properly placed and the fallopian tubes are fully blocked, giving the patient reliance on Essure for permanent birth control. Essure has been proven and trusted by physicians since 2002, with nearly 500,000 women worldwide having undergone the Essure procedure.
Conceptus revenue & valuation
| Annual revenue | $134,200,000 |
| Revenue per employee | $1,491,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Medical Equipment Manufacturing industry and current estimated revenues | $429,200,000 |
| Total funding | No funding |
Employees by Management Level
Total employees: 51-100
Seniority
Employees
Employees by Department
Conceptus has 17 employees across 7 departments.
Departments
Number of employees
Funding Data
Conceptus has never raised funding before.
Conceptus Tech Stack
Discover the technologies and tools that power Conceptus's digital infrastructure, from frameworks to analytics platforms.
PaaS
PaaS
CDN
Reverse proxies
Programming languages
Security
CMS
Latvia
Australia
Canada
Dominican Republic
Frequently asked questions
4.8
40,000 users
